The first generic version of conjugated estrogens tablets is now available nationwide in 5 different strengths.

The approval was based on data from the single-arm, open-label phase 2 KOMET-001 trial, which evaluated ziftomenib, a menin inhibitor, in adults with R/R AML with an NPM1 mutation.

Rates higher among those aged 18 to 21 years, and more than nine in 10 users found the advice somewhat or very helpful.

Topline results were announced from a phase 3 trial evaluating bictegravir 75mg/lenacapavir 50mg (BIC/LEN), an investigational single-tablet regimen for the treatment of HIV-1.

However, myocardial infarction risk and cerebrovascular accident risk higher in transgender men compared with general population of women ...

However, youth continuing to vape are showing signs of worsening addiction, including daily use and unsuccessful quitting.

Decrease in mean systolic BP seen for those receiving home-delivered DASH-patterned groceries and dietitian counseling ...

The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to induce electrical currents in localized regions of the prefrontal cortex.

“Once-daily icotrokinra, a systemic targeted oral peptide binding to the interleukin-23 receptor, was effective for treating plaque psoriasis in adults and in adolescents, an age group with limited ...

Study also revealed no increased risk for major adverse cardiovascular events for patients on a GLP-1 RA vs those not on a GLP-1 RA.

During 5 years of follow-up, incident heart failure occurred in 3021 melatonin users (4.6%) vs 1797 controls (2.7%; hazard ratio, 1.89). (HealthDay News) — Long-term melatonin use for treatment of ...

The novel extended-release formulation is expected to prevent both acute and delayed CINV for up to 5 days, improving patient compliance and convenience.